Literature DB >> 2536349

Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma.

G Leray1, Y Deugnier, A M Jouanolle, D Lehry, J F Bretagne, J P Campion, P Brissot, A Le Treut.   

Abstract

Biochemical characteristics of alpha-L-fucosidase (alpha-L-fucoside hydrolase, EC 3.2.1.51) were studied in tumorous and nontumorous human hepatocellular carcinoma (n = 14). Five parameters were studied: (i) specific activity, (ii) thermostability, (iii) enzyme affinity for an artificial substrate (Km), (iv) isoenzyme patterns of the glycosidase before and after neuraminidase treatment and (v) pH influence on enzyme activity. The specific activity of alpha-L-fucosidase was significantly decreased in tumoral liver when compared to nontumoral liver. The curve of pH activity constantly showed a broad optimum centered near pH 5, whereas two optima were always observed in nontumoral areas. In contrast, there was no modification of the thermostability, the substrate affinity and the isoenzyme patterns of alpha-L-fucosidase in hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536349     DOI: 10.1002/hep.1840090214

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue.

Authors:  Chao Li; Jie Qian; Ju-Sheng Lin
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

2.  Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis.

Authors:  S Bloom; A Heryet; K Fleming; R W Chapman
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

3.  The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease.

Authors:  Ma'en Obeidat; Xiaoting Ding; Nick Fishbane; Zsuzsanna Hollander; Raymond T Ng; Bruce McManus; Scott J Tebbutt; Bruce E Miller; Stephen Rennard; Peter D Paré; Don D Sin
Journal:  Nicotine Tob Res       Date:  2016-05-06       Impact factor: 4.244

4.  Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?

Authors:  F Marotta; D H Chui; P Safran; S C Zhang
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

5.  Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.

Authors:  K Wang; W Guo; N Li; J Shi; C Zhang; W Y Lau; M Wu; S Cheng
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

Review 6.  Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.

Authors:  Massimiliano Berretta; Carla Cavaliere; Lara Alessandrini; Brigida Stanzione; Gaetano Facchini; Luca Balestreri; Tiziana Perin; Vincenzo Canzonieri
Journal:  Oncotarget       Date:  2017-02-21

7.  Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.

Authors:  Xiangyang Yu; Rusi Zhang; Tianzhen Yang; Mengqi Zhang; Kexing Xi; Yongbin Lin; Yingsheng Wen; Gongming Wang; Zirui Huang; Xuewen Zhang; Lanjun Zhang
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

8.  Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors.

Authors:  Olalla Otero-Estévez; Mónica Martínez-Fernández; Lorena Vázquez-Iglesias; María Páez de la Cadena; Francisco J Rodríguez-Berrocal; Vicenta S Martínez-Zorzano
Journal:  Int J Mol Sci       Date:  2013-08-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.